Atreca, Inc.
BCELDelisted Mar 20, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001532346
Atreca, Inc. was delisted on Mar 20, 2024; its insiders filed their last Form 4 on Apr 17, 2024; 43 institutions reported holding it in 13F filings for Q4 2023, worth $1.24M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Atreca, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 53
- −1 vs. Q1 2023
- Shares held
- 13.7M
- −628.6K (−4.4%) vs. Q1 2023
- Total value
- $13.4M
- −$2.91M (−17.8%) vs. Q1 2023
- New holders
- 3
- 7 more added
- Sold out
- 4
- 14 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 7 | $79.4K |
| Q4 2023 | 43 | $1.24M |
| Q3 2023 | 45 | $3.24M |
| Q2 2023 | 53 | $13.4M |
| Q1 2023 | 54 | $16.3M |
| Q4 2022 | 59 | $11.6M |
| Q3 2022 | 65 | $25.1M |
| Q2 2022 | 80 | $29.8M |
| Q1 2022 | 93 | $60.9M |
| Q4 2021 | 100 | $65.7M |
| Q3 2021 | 107 | $145.8M |
| Q2 2021 | 108 | $233.5M |
| Q1 2021 | 105 | $428.1M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Atreca, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 10 | $0 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 23 | $23 | 0.00% | 00.0% | Unchanged |
| Beaird Harris Wealth Management, LLC | 77 | $76 | 0.00% | 00.0% | Unchanged |
| Salem Investment Counselors Inc | 85 | $84 | 0.00% | 00.0% | Unchanged |
| Investors Research Corp | 200 | $196 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 213 | $209 | 0.00% | +213 | New |
| Citadel Advisors LLC | 440 | $431 | 0.00% | −7,028−94.1% | Reduced |
| Federation des caisses Desjardins du Quebec | 440 | $431 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 500 | $490 | 0.00% | +500 | New |
| Royal Bank of Canada | 1,009 | $1.00K | 0.00% | +135+15.4% | Added |
| Ronald Blue Trust, Inc. | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 1,600 | $1.57K | 0.00% | 00.0% | Unchanged |
| PFS Partners, LLC | 1,990 | $1.95K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,215 | $2.17K | 0.00% | −3,291−59.8% | Reduced |
| Group One Trading, L.P. | 5,000 | $4.90K | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 8,114 | $7.95K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 8,433 | $8.26K | 0.00% | +2,002+31.1% | Added |
| Stifel Financial Corp | 10,191 | $9.99K | 0.00% | −806−7.3% | Reduced |
| Endurance Wealth Management, Inc. | 10,600 | $10.0K | 0.00% | 00.0% | Unchanged |
| Sand Hill Global Advisors, LLC | 12,500 | $12.3K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 14,239 | $14.0K | 0.00% | +14,239 | New |
| Advisor Group Holdings, Inc. | 15,129 | $14.8K | 0.00% | −2,244−12.9% | Reduced |
| Bank of New York Mellon Corp | 15,155 | $14.9K | 0.00% | −16,652−52.4% | Reduced |
| CI Private Wealth, LLC | 20,000 | $19.6K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 22,959 | $22.5K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 24,811 | $24.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 38,994 | $38.2K | 0.00% | −47,803−55.1% | Reduced |
| Acadian Asset Management LLC | 44,110 | $42.0K | 0.00% | −21,747−33.0% | Reduced |
| Barclays PLC | 47,487 | $46.5K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 59,168 | $58.0K | 0.00% | −4,679−7.3% | Reduced |
| Millennium Management LLC | 73,702 | $72.2K | 0.00% | −58,385−44.2% | Reduced |
| Goldman Sachs Group Inc | 75,752 | $74.2K | 0.00% | +186+0.2% | Added |
| Raymond James & Associates | 77,500 | $76.0K | 0.00% | −240.0% | Reduced |
| State Street Corp | 91,520 | $89.7K | 0.00% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 105,283 | $103.2K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 107,685 | $105.5K | 0.00% | +247+0.2% | Added |
| FMR LLC | 110,179 | $108.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 150,000 | $147.0K | 0.00% | +50,000+50.0% | Added |
| Geode Capital Management, LLC | 248,980 | $244.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 315,624 | $309.0K | 0.00% | +18,300+6.2% | Added |
| Cormorant Asset Management, LP | 319,057 | $312.7K | 0.02% | 00.0% | Unchanged |
| CM Management, LLC | 350,000 | $343.0K | 0.33% | +75,000+27.3% | Added |
| Rock Springs Capital Management LP | 362,530 | $355.3K | 0.01% | 00.0% | Unchanged |
| Aisling Capital Management LP | 387,653 | $379.9K | 0.19% | 00.0% | Unchanged |
| Laurion Capital Management LP | 429,176 | $420.6K | 0.02% | −63,024−12.8% | Reduced |
| Redmile Group, LLC | 442,653 | $433.8K | 0.02% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 466,828 | $457.0K | 0.01% | −43,058−8.4% | Reduced |
| Bill & Melinda Gates Foundation | 931,815 | $913.2K | 0.73% | −74,764−7.4% | Reduced |
| BlackRock Inc. | 1,191,785 | $1.17M | 0.00% | −153,858−11.4% | Reduced |
| Vanguard Group Inc | 1,328,923 | $1.30M | 0.00% | 00.0% | Unchanged |
| Boxer Capital, LLC | 2,202,333 | $2.16M | 0.10% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 3,532,760 | $3.46M | 0.02% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 0 | $0 | 0.00% | −262,827−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −15,133−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −13,909−100.0% | Sold out |
| Hantz Financial Services, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |